UBS Group’s SomaLogic Warrant SLGCW Stock Holding History
Bought
Maintained
Sold
Other funds holding SLGCW
UBS Group's SLGCW Position: Q1 2024 in Review
UBS Group sold out of SomaLogic Warrant (SLGCW) in Q1 2024, closing a stake of 317 shares — an estimated $38 sold.
UBS Group first reported a position in SLGCW in Q2 2021 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.
- UBS Group reported no remaining SomaLogic Warrant position as of Q1 2024 after selling out during the quarter.
- UBS Group sold 317 SomaLogic Warrant shares in Q1 2024, an estimated $38.
- UBS Group first reported a position in SomaLogic Warrant in Q2 2021 and held it in 8 quarters.
- UBS Group's SomaLogic Warrant position peaked at $3K in Q4 2021.
- 4 funds tracked by Wall St. Rank held SomaLogic Warrant as of Q1 2024.
Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.